Nazneen N Dewji
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2015First federal award
$11.8MFederal grants as PI14 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
14 awards · $11.8M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Aug 5, 2025 | NIH | SBIR Phase II EARLY CLINICAL DEVELOPMENT OF MODIFIED P8 FOR THE TREATMENT OF ALZHEIMER'S DISEASE | $1.6M | CENNA BIOSCIENCES INC |
| Sep 19, 2024 | NIH | SBIR Phase II EARLY CLINICAL DEVELOPMENT OF MODIFIED P8 FOR THE TREATMENT OF ALZHEIMER'S DISEASE | $1.0M | CENNA BIOSCIENCES INC |
| Aug 17, 2021 | NIH | SBIR Phase II IND-Enabling Pre-clinical Development of Modified P8 for the Treatment of Alzheimer's Disease | $101K | CENNA BIOSCIENCES INC |
| Jul 6, 2021 | NIH | SBIR Phase II IND-Enabling Pre-clinical Development of Modified P8 for the Treatment of Alzheimer's Disease | $1.6M | CENNA BIOSCIENCES INC |
| Sep 11, 2020 | NIH | SBIR Phase II IND-Enabling Pre-clinical Development of Modified P8 for the Treatment of Alzheimer's Disease | $1.8M | CENNA BIOSCIENCES INC |
| Aug 31, 2019 | NIH | SBIR Phase II Small molecule therapeutics for Alzheimer's Disease | $375K | CENNA BIOSCIENCES INC |
| Apr 19, 2019 | NIH | SBIR Phase II Small molecule therapeutics for Alzheimer's Disease | $1000K | CENNA BIOSCIENCES INC |
| Sep 20, 2018 | NIH | SBIR Phase II Small molecule therapeutics for Alzheimer's Disease | $1000K | CENNA BIOSCIENCES INC |
| Jun 25, 2018 | NIH | SBIR Phase II Progressing the Pre-clinical development of P8 for Alzheimer's Disease | $748K | CENNA BIOSCIENCES INC |
| Sep 8, 2017 | NIH | SBIR Phase II Progressing the Pre-clinical development of P8 for Alzheimer's Disease | $750K | CENNA BIOSCIENCES INC |
| Aug 31, 2017 | NIH | SBIR Phase II Intranasal Delivery of Peptide Drugs to the Brain | $100K | CENNA BIOSCIENCES INC |
| Sep 21, 2016 | NIH | SBIR Phase I Small molecule therapeutics for Alzheimer's Disease | $225K | CENNA BIOSCIENCES INC |
| May 11, 2016 | NIH | SBIR Phase II Intranasal Delivery of Peptide Drugs to the Brain | $747K | CENNA BIOSCIENCES INC |
| May 18, 2015 | NIH | SBIR Phase II Intranasal Delivery of Peptide Drugs to the Brain | $750K | CENNA BIOSCIENCES INC |
Peer ranks
Federal funding#43
Awards as PI#57
Patents#273
Companies
- CENNA BIOSCIENCES INCLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.